Product Overview

Vilitra 20 mg is a prescription medication formulated to address erectile dysfunction in adult men. Manufactured by Centurion Laboratories Pvt. Ltd., each strip contains ten film‑coated tablets that deliver a consistent 20 mg dose of vardenafil, a phosphodiesterase‑5 (PDE5) inhibitor. The product is packaged for convenient use and is shipped with a reliable delivery window of six to fifteen days, ensuring that patients receive a genuine, quality‑assured therapy for improving sexual performance. The tablets are film‑coated to protect the active ingredient from degradation and to provide a smooth swallowing experience. This formulation is intended for use on an as‑needed basis, allowing men to achieve and maintain a firm erection when sexual stimulation occurs.

What is Vilitra 20 mg

Vilitra 20 mg contains vardenafil, a selective inhibitor of the phosphodiesterase‑5 enzyme that plays a central role in the physiological process of penile erection. By blocking PDE5, vardenafil promotes the accumulation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum, leading to relaxation of smooth muscle and increased blood flow. This mechanism facilitates the attainment of a rigid erection sufficient for satisfactory sexual activity. The 20 mg strength is the most commonly prescribed dose for men who have not previously used vardenafil or who require a standard therapeutic level. Clinical studies have demonstrated that Vilitra is effective in approximately 70 % of patients with ED, regardless of the underlying cause.

Uses and Benefits

The primary indication for Vilitra 20 mg is the treatment of erectile dysfunction, a condition characterized by the inability to achieve or sustain an erection adequate for sexual intercourse. In addition to its primary use, clinicians may consider Vilitra as part of a broader management plan that includes lifestyle modifications, psychological counseling, and treatment of comorbid medical conditions such as diabetes or hypertension. Patients often report improved confidence, reduced anxiety related to performance, and enhanced intimacy when the medication works as intended. The tablet’s rapid onset of action—typically within 30 to 60 minutes after oral administration—allows for spontaneity, while its duration of effect, lasting up to five hours, provides a generous window for sexual activity.

How It Works

Vilitra’s active ingredient, vardenafil, belongs to the class of phosphodiesterase‑5 inhibitors. During sexual stimulation, nitric oxide is released in the penile tissue, activating the enzyme guanylate cyclase and increasing levels of cyclic GMP. This messenger molecule relaxes smooth muscle cells, widening blood vessels and allowing more blood to fill the erectile tissue. Vardenafil prevents the premature breakdown of cyclic GMP by inhibiting PDE5, thereby sustaining the relaxation response. The result is a firm and durable erection that can be maintained as long as sexual arousal persists. It is important to note that Vilitra does not increase sexual desire; it merely supports the physiological mechanisms that enable an erection when a man is already sexually stimulated. For more detailed information, see the FDA prescribing information.

Dosage Guidelines

Vilitra 20 mg should be taken orally, usually about one hour before anticipated sexual activity. The tablet can be consumed with or without food, though a high‑fat meal may delay absorption and reduce peak plasma concentrations. The recommended starting dose for most men is one tablet per day, and it should not be exceeded. If a dose is missed, it should not be doubled; simply continue with the next scheduled dose. Patients with hepatic impairment or those taking certain antifungal or antibacterial agents may require dose adjustment, and such individuals should consult a healthcare professional before use. It is essential to adhere to the prescribed dosing schedule to achieve optimal efficacy while minimizing the risk of adverse effects.

Side Effects

Like all medications, Vilitra 20 mg can cause side effects, although many are mild and transient. The most commonly reported adverse reactions include headache, facial flushing, nasal congestion, and dizziness. Some users may experience gastrointestinal discomfort, blurred vision, or a temporary change in color perception. In rare cases, more serious events such as prolonged erections (priapism), sudden hearing loss, or cardiac arrhythmias have been reported. If any of these symptoms persist or worsen, medical attention should be sought promptly. For additional safety information, refer to MedlinePlus.

Warnings and Precautions

Vilitra is contraindicated in patients who are taking nitrates, such as nitroglycerin or isosorbide mononitrate, as the combination can cause a dangerous drop in blood pressure. Individuals with severe cardiovascular disease, uncontrolled hypertension, or a recent history of stroke or myocardial infarction should use the medication with caution and only under medical supervision. It is not intended for use in women or children under the age of 18. Patients should inform their healthcare provider of all concomitant medications, including over‑the‑counter drugs and herbal supplements, to avoid potentially harmful interactions. Proper storage at room temperature, away from moisture and heat, helps maintain the integrity of the tablets throughout the six‑to‑fifteen‑day shipping period.

Frequently Asked Questions

Related Products

• LDN 1.5 Mg (Naltrexone)
• LDN 3 Mg (Naltrexone)
• LDN 4.5 Mg (Naltrexone)
• Naltrexone 4.5mg (Generic)
• Naltrexone 3 mg (Generic)
• Naltrexone 1.5 mg (Generic)
• Sildenafil Oral Disintegrating Strips
• Siezta 100 Mg (Sildenafil Citrate)
• Orgie 20 Mg (Tadalafil)
• Pirfenidone 200 mg (Pirfenidone)
• Vega Polo (Sildenafil Citrate)
• Filagra FXT Plus (Sildenafil Citrate/Fluoxetine)